Professor, Psychiatry and Human Behavior, University of California, Irvine College of Medicine
Psychiatry
Dr. Steven G. Potkin, MD
|
|
Give Review
Doctor Steven G. Potkin, MD works in the field of Psychiatry. He attended Washington University School of Medicine in St. Louis. Doctor Steven G. Potkin, MD is a published doctor. He has 76 papers published. The most current publication "Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia."
Publications
- Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia.
- Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin.
- Relating Intrinsic Low-Frequency BOLD Cortical Oscillations to Cognition in Schizophrenia.
- Understanding responder neurobiology in schizophrenia using a quantitative systems pharmacology model: Application to iloperidone.
- Building a roadmap for developing combination therapies for Alzheimer's disease.
- Imaging genetics approaches to identify mechanisms in severe mental illness.
- Visual Hallucinations Are Associated With Hyperconnectivity Between the Amygdala and Visual Cortex in People With a Diagnosis of Schizophrenia.
- Schizophrenia miR-137 Locus Risk Genotype Is Associated with Dorsolateral Prefrontal Cortex Hyperactivation.
- Transposable elements and psychiatric disorders.
- Converting positive and negative symptom scores between PANSS and SAPS/SANS.
- The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.
- A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.
- Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers.
- Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex.
- Long-term effects of asenapine or olanzapine in patients with persistent negative symptoms of schizophrenia: A pooled analysis.
- D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder.
- Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than a...
- An application of item response theory to fMRI data: Prospects and pitfalls.
- Development of the readiness for work questionnaire in schizophrenia.
- Gating of a novel brain potential is associated with perceptual anomalies in bipolar disorder.
- Increased CNV-Region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample.
- Efficacy and safety of lurasidone 80mg/day and 160mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial.
- A Thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
- Exogenous delivery of chaperonin subunit fragment ApiCCT1 modulates mutant Huntingtin cellular phenotypes.
- Next Generation Sequence Analysis and Computational Genomics Using Graphical Pipeline Workflows.
- Feed-forward hierarchical model of the ventral visual stream applied to functional brain image classification.
- Identification of common variants associated with human hippocampal and intracranial volumes.
- Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: Replication and exploration.
- Alpha EEG guided TMS in schizophrenia.
- The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response.
- Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder.
- Assessment of psychological pain in major depressive episodes.
- SNP-based pathway enrichment analysis for genome-wide association studies.
- A novel method for quantifying scanner instability in fMRI.
- A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
- Asenapine: a clinical overview.
- Identifying gene regulatory networks in schizophrenia.
- Using new antipsychotics in your clinical practice.
- A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus halop...
- What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?
- Dropouts and missing data in psychiatric clinical trials.
- Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder.
- Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.
- Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia.
- Brain-performance correlates of working memory retrieval in schizophrenia: a cognitive modeling approach.
- Widespread cortical dysfunction in schizophrenia: the FBIRN imaging consortium.
- Test-retest and between-site reliability in a multicenter fMRI study.
- Chronic smoking and the BOLD response to a visual activation task and a breath hold task in patients with schizophrenia and healthy controls.
- Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.
- New advances in the treatment of schizophrenia. Introduction.
- Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trial.
- Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response.
- Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation study.
- Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition.
- Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
- Alpha EEG predicts visual reaction time.
- Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.
- Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia.
- Imaging phenotypes and genotypes in schizophrenia.
- Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
- A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.
- Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman pr...
- Alzheimer disease and other dementias.
- Memory for emotional stimuli in patients with Alzheimer's disease.
- Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
- Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.
- MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients.
- Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.
- Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia.
- The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
- A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.
- The ABC of Alzheimer's disease: ADL and improving day-to-day functioning of patients.
- A multi-site resting state fMRI study on the amplitude of low frequency fluctuations in schizophrenia.
- Dynamic functional connectivity analysis reveals transient states of dysconnectivity in schizophrenia.
- Brown adipose tissue quantification in human neonates using water-fat separated MRI.
Schools
Washington Center School of Medicine
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
Duke University Hospital -
Washington University School of Medicine in St. Louis
Helpful Reviews
Similar Doctors
|
|
Angela H. Yu
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vinayak S. Shanbhag, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Albin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Adrian Preda, MD |
|
|
Dr. Aaron D. Kheriaty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sara E. Vogel, MD |
|
|
Dr. Atur V. Turakhia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tina M. Allee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stella Cai, MD |